268 related articles for article (PubMed ID: 28848060)
21. Intrafamilial correlation of clinical manifestations in neurofibromatosis 2 (NF2).
Zhao Y; Kumar RA; Baser ME; Evans DG; Wallace A; Kluwe L; Mautner VF; Parry DM; Rouleau GA; Joe H; Friedman JM
Genet Epidemiol; 2002 Oct; 23(3):245-59. PubMed ID: 12384977
[TBL] [Abstract][Full Text] [Related]
22. Genomics, Epigenetics, and Hearing Loss in Neurofibromatosis Type 2.
Dinh CT; Nisenbaum E; Chyou D; Misztal C; Yan D; Mittal R; Young J; Tekin M; Telischi F; Fernandez-Valle C; Liu XZ
Otol Neurotol; 2020 Jun; 41(5):e529-e537. PubMed ID: 32150022
[TBL] [Abstract][Full Text] [Related]
23. Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: a study of 24 patients.
Ruggieri M; Iannetti P; Polizzi A; La Mantia I; Spalice A; Giliberto O; Platania N; Gabriele AL; Albanese V; Pavone L
Neuropediatrics; 2005 Feb; 36(1):21-34. PubMed ID: 15776319
[TBL] [Abstract][Full Text] [Related]
24. Neurofibromatosis 2 phenotypes and germ-line NF2 mutations determined by an RNA mismatch method and loss of heterozygosity analysis in NF2 schwannomas.
Hung G; Faudoa R; Baser ME; Xue Z; Kluwe L; Slattery W; Brackman D; Lim D
Cancer Genet Cytogenet; 2000 Apr; 118(2):167-8. PubMed ID: 10748301
[TBL] [Abstract][Full Text] [Related]
25. A missense mutation in the NF2 gene results in moderate and mild clinical phenotypes of neurofibromatosis type 2.
Kluwe L; Mautner VF
Hum Genet; 1996 Feb; 97(2):224-7. PubMed ID: 8566958
[TBL] [Abstract][Full Text] [Related]
26. [Type 2 neurofibromatosis: intergenerational differences in genetic and clinical expression].
Drouet A; Le Moigne F; Salamé D; Quesnel L; Motolese C; des Portes V; Guilloton L; Pinson S
Arch Pediatr; 2014 Nov; 21(11):1233-40. PubMed ID: 25439059
[TBL] [Abstract][Full Text] [Related]
27. Clinical features of spinal schwannomas in 65 patients with schwannomatosis compared with 831 with solitary schwannomas and 102 with neurofibromatosis Type 2: a retrospective study at a single institution.
Li P; Zhao F; Zhang J; Wang Z; Wang X; Wang B; Yang Z; Yang J; Gao Z; Liu P
J Neurosurg Spine; 2016 Jan; 24(1):145-54. PubMed ID: 26407091
[TBL] [Abstract][Full Text] [Related]
28. Genotype-phenotype correlations for nervous system tumors in neurofibromatosis 2: a population-based study.
Baser ME; Kuramoto L; Joe H; Friedman JM; Wallace AJ; Gillespie JE; Ramsden RT; Evans DG
Am J Hum Genet; 2004 Aug; 75(2):231-9. PubMed ID: 15190457
[TBL] [Abstract][Full Text] [Related]
29. Mutations and allelic loss of the NF2 gene in neurofibromatosis 2-associated skin tumors.
Kluwe L; Friedrich RE; Hagel C; Lindenau M; Mautner VF
J Invest Dermatol; 2000 May; 114(5):1017-21. PubMed ID: 10771486
[TBL] [Abstract][Full Text] [Related]
30. Revisiting the UK Genetic Severity Score for NF2: a proposal for the addition of a functional genetic component.
Catasús N; Garcia B; Galván-Femenía I; Plana A; Negro A; Rosas I; Ros A; Amilibia E; Becerra JL; Hostalot C; Rocaribas F; Bielsa I; Lazaro Garcia C; de Cid R; Serra E; Blanco I; Castellanos E;
J Med Genet; 2022 Jul; 59(7):678-686. PubMed ID: 34348961
[TBL] [Abstract][Full Text] [Related]
31. Neurofibromatosis type 2 and related disorders.
Halliday D; Parry A; Evans DG
Curr Opin Oncol; 2019 Nov; 31(6):562-567. PubMed ID: 31425178
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value and management of spinal tumors in neurofibromatosis type 2 patients.
Aboukais R; Baroncini M; Zairi F; Bonne NX; Schapira S; Vincent C; Lejeune JP
Acta Neurochir (Wien); 2013 May; 155(5):771-7. PubMed ID: 23381342
[TBL] [Abstract][Full Text] [Related]
33. Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease.
Ruttledge MH; Andermann AA; Phelan CM; Claudio JO; Han FY; Chretien N; Rangaratnam S; MacCollin M; Short P; Parry D; Michels V; Riccardi VM; Weksberg R; Kitamura K; Bradburn JM; Hall BD; Propping P; Rouleau GA
Am J Hum Genet; 1996 Aug; 59(2):331-42. PubMed ID: 8755919
[TBL] [Abstract][Full Text] [Related]
34. Probability of bilateral disease in people presenting with a unilateral vestibular schwannoma.
Evans DG; Lye R; Neary W; Black G; Strachan T; Wallace A; Ramsden RT
J Neurol Neurosurg Psychiatry; 1999 Jun; 66(6):764-7. PubMed ID: 10329751
[TBL] [Abstract][Full Text] [Related]
35. Neurofibromatosis type 2.
Evans DG
Handb Clin Neurol; 2015; 132():87-96. PubMed ID: 26564072
[TBL] [Abstract][Full Text] [Related]
36. Long-term follow-up studies of Gamma Knife surgery for patients with neurofibromatosis Type 2.
Sun S; Liu A
J Neurosurg; 2014 Dec; 121 Suppl():143-9. PubMed ID: 25434947
[TBL] [Abstract][Full Text] [Related]
37. In Silico Analysis of NF2 Gene Missense Mutations in Neurofibromatosis Type 2: From Genotype to Phenotype.
Heineman TE; Evans DG; Campagne F; Selesnick SH
Otol Neurotol; 2015 Jun; 36(5):908-14. PubMed ID: 25931164
[TBL] [Abstract][Full Text] [Related]
38. Multiple meningiomas: differential involvement of the NF2 gene in children and adults.
Evans DG; Watson C; King A; Wallace AJ; Baser ME
J Med Genet; 2005 Jan; 42(1):45-8. PubMed ID: 15635074
[TBL] [Abstract][Full Text] [Related]
39. Diagnosis, Management, and New Therapeutic Options in Childhood Neurofibromatosis Type 2 and Related Forms.
Ruggieri M; Praticò AD; Evans DG
Semin Pediatr Neurol; 2015 Dec; 22(4):240-58. PubMed ID: 26706012
[TBL] [Abstract][Full Text] [Related]
40. [Neurofibromatosis type 2 (central neurofibromatosis or bilateral acoustic neuromas, vestibular schwannomas): from phenotype to gene].
Sabol Z; Kipke-Sabol L; Miklić P; Hajnsek-Propadalo S; Sabol F
Lijec Vjesn; 2006; 128(9-10):309-16. PubMed ID: 17128670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]